about
Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesisRegulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsDirect estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell linesTherapeutic Considerations in Treating HER2-Positive Metastatic Breast CancerProfiling epidermal growth factor receptor and heregulin receptor 3 heteromerization using receptor tyrosine kinase heteromer investigation technology.ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas.HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe.HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.The Potential of panHER Inhibition in Cancer.Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations.Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neuronsDietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention
P2860
Q24630499-0F8C9297-A4E3-4239-89E4-3AFE7043FE94Q24631327-80B5E00F-58CF-46DD-82E4-7589368217A7Q33664216-8A14FA56-C2FE-4E62-A75D-E3AD1FE9B382Q33822560-C21FEAF1-1179-4670-87CA-3F0FBACFDE09Q34268618-7DB51652-4DCF-4E42-9C3C-3737720B9F1DQ34735615-3BB8113F-8063-4C4E-B669-67EB915E2167Q36677496-12BC06AF-2CA2-49BC-A256-60C83D5A4E7FQ36698389-8E93669A-79BD-47B2-BCA7-FC7533D91C1FQ37385372-C70AA117-4BDC-4763-B86D-6C5E9EE84715Q37407344-485DB8A0-F13B-409C-AA8D-E7F91F731FF5Q38192017-AE23D8A9-B71D-4BD3-8805-599CA68F37D3Q38352587-8530396F-DAA9-4EEA-8E88-9E5AE77FDA18Q38861026-5C0F33AF-59B2-426F-A64F-BEE9F7B16153Q42575747-91B727BB-B2EF-4124-8C67-E586EF93CF1DQ58793547-D5867FC1-7E67-46CC-A73D-B0B4592ECC76
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of HER2/HER3 co-receptor in breast carcinogenesis.
@ast
Role of HER2/HER3 co-receptor in breast carcinogenesis.
@en
type
label
Role of HER2/HER3 co-receptor in breast carcinogenesis.
@ast
Role of HER2/HER3 co-receptor in breast carcinogenesis.
@en
prefLabel
Role of HER2/HER3 co-receptor in breast carcinogenesis.
@ast
Role of HER2/HER3 co-receptor in breast carcinogenesis.
@en
P2860
P356
P1433
P1476
Role of HER2/HER3 co-receptor in breast carcinogenesis.
@en
P2093
Jen-Kun Lin
Tzong-Der Way
P2860
P304
P356
10.2217/14796694.1.6.841
P407
P577
2005-12-01T00:00:00Z